Sonus Pharmaceuticals regulatory update

Sonus (Bothell, Wash.) received U.S. Patent No. 5,393,524 covering its High-Q Factor technology that uses fluorocarbon gases as ultrasound contrast media. The patent claims a method of performing impr...